Skip to main content

Table 1 Cohort characteristics

From: Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study

  Control ESRD-HD ESRD-PD Transplant
N (blood/stool) 13/11 8/7 8/7 10/9
Sex (male:female) 6:7 5:3 4:4 10:0
Age (years) 9.5 (3–16) 13.6 (8–17) 11.9 (3-17) 13.2 (2–18)
BMI (kg/m2) 23.15 (14.9–53) 22.1 (16.6–28) 17.8 (14.8–23.4) 18.8 (15.3–23.8)
Time on dialysis (months) N/A 23.3 (2–77) 21.5 (3–49) N/A
Kt/v N/A 1.8 (1.22–2.7) 2.2 (1.89–2.5) N/A
Time from transplant (month) N/A N/A N/A 43.1 (10–110)
BUN (mg/dl) 13.54 (8–19) 51.00 (33–125) 41.38 (14–65) 17.78 (9–26)
Serum creatinine (mg/dl) 0.37 (0.10–0.70) 8.58 (0.90–18.10) 11.70 (7.40–19.00) 0.99 (0.50–1.60)
eGFR 118 (85-139) <15 <15 78 (61–108)
  1. ESRD-HD end-stage renal disease on hemodialysis, ESRD-PD end-stage renal disease on peritoneal dialysis, N/A not available, N number of samples, Kt/v dialysis dose, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate